Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13918257 | 0.87 | POLB (0.46) | POLBEPHX1 | |
| SCHEMBL16221827 | 0.84 | RIPK1 (0.36) | POLBEPHX1 | |
| SCHEMBL13395903 | 0.82 | — | — | |
| SCHEMBL18677700 | 0.82 | POLB (0.34) | POLBEPHX1 | |
| SCHEMBL16592001 | 0.81 | POLB (0.35) | POLBEPHX1 | |
| SCHEMBL18677679 | 0.80 | POLB (0.41) | POLBEPHX1 | |
| SCHEMBL25993257 | 0.80 | POLB (0.37) | POLBEPHX1 | |
| SCHEMBL24093564 | 0.80 | POLB (0.41) | POLBEPHX1 | |
| SCHEMBL21241099 | 0.79 | POLB (0.34) | POLBEPHX1 | |
| SCHEMBL16221829 | 0.79 | POLB (0.34) | POLBEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230059250-A1 | Anti-CD37 Antibody-Maytansine Conjugates and Methods of Use Thereof | ARES CAPITAL CORPORATION, AS COLLATERAL AGENT | 2023-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230059250-A1 | Anti-CD37 Antibody-Maytansine Conjugates and Methods of Use Thereof | SIGLEC7, FUT7, CD2 | POLB 4669/4885EPHX1 1524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.